Billionaire Profile
Xie Liangzhi & family
Global Rank
#1694

Image: Unsplash Contributor | Unsplash License | via Unsplash

Xie Liangzhi & family

CEO, Biotech
CHINA
Real-Time Net Worth
$2.443B
Estimated based on Biotech stock value as of March 6, 2026
+6.07% (24h)
Age
60
Source
Biotech
Industry
Healthcare
Citizenship
CHINA

Biography

Xie Liangzhi, a prominent figure in the biotech industry, is the chairman of the Beijing-based Sinocelltech Group, a supplier of biological products. With an estimated net worth of $2.6 billion as of 2024, Xie's wealth stems from his successful ventures in the biotech sector. He holds a Ph.D. in chemical engineering from the Massachusetts Institute of Technology (MIT). Xie's career includes significant roles at Merck & Co., where he worked on viral vaccine process development and manufacturing. He is married and resides in Beijing, China.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Xie Liangzhi, a Chinese citizen, earned his Ph.D. in chemical engineering from the Massachusetts Institute of Technology (MIT). He also holds a bachelor's and master's degree from Dalian University of Technology.

Rise to Success

Xie's career began in 1996 when he joined Merck & Co. He worked on the development and production technologies for several vaccines. In 2002, after 12 years in the United States, Xie returned to China to start his own business. He founded Sinocelltech Group, a biotech company focused on biological products.

Key Business Strategies

Xie chairs Sinocelltech, which has undertaken numerous scientific and technological development projects. His experience in viral vaccine development and cGMP manufacturing has been crucial to his success.

Philanthropy

Information regarding Xie's specific philanthropic initiatives is not readily available. However, his leadership in the biotech sector indicates a commitment to advancing healthcare solutions.

Career Milestones

1996

Research Fellow

Joined Merck & Co. and worked on viral vaccine development and manufacturing.

2002

Founded Sino Biological Inc.

Returned to China to start a biomedical high-tech company.

2007

President and CEO of Sino Biological Inc.

Headed Sino Biological Inc, focused on research reagents and CRO services.

Philanthropy & Social Impact

N/A

Not Available

Undisclosed

Information not available.

Business Philosophy & Leadership

Notable Quotes

"Information not available."

Leadership Principles

Not Available

Information not available.

Controversies & Challenges

N/A

N/A

No information available.